XML 121 R39.htm IDEA: XBRL DOCUMENT v3.6.0.2
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)
 12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss)
A summary of changes in the balances of each component of accumulated other comprehensive loss, net of tax, follows:
 
Defined Benefit Plans
 
Unrealized Losses on Securities
 
Translation Adjustment
 
Total
Balance at January 1, 2014
$
(410
)
 
$
(5
)
 
$
10

 
$
(405
)
Amounts arising during the perioda,b
(162
)
 
(1
)
 
—

 
(163
)
Amounts reclassifiedc
24

 
—

 
—

 
24

Balance at December 31, 2014
(548
)
 
(6
)
 
10

 
(544
)
Amounts arising during the perioda,b
3

 
—

 
—

 
3

Amounts reclassifiedc
38

 
—

 
—

 
38

Balance at December 31, 2015
(507
)
 
(6
)
 
10

 
(503
)
Amounts arising during the perioda,b
(91
)
 
2

 
—

 
(89
)
Amounts reclassifiedc
44

 
—

 
—

 
44

Balance at December 31, 2016
$
(554
)
 
$
(4
)
 
$
10

 
$
(548
)
a.
Includes net actuarial losses, net of noncontrolling interest, totaling $252 million for 2014, $7 million for 2015 and $79 million for 2016.
b.
Includes tax benefits (provision) totaling $89 million for 2014, $2 million for 2015 and $(11) million for 2016.
c.
Includes amortization primarily related to actuarial losses, net of taxes, of $14 million for 2014, $16 million for 2015 and $4 million for 2016.
Compensation costs charged against earnings
Compensation cost charged against earnings for stock-based awards for the years ended December 31 follows:
 
 
2016
 
2015
 
2014
Selling, general and administrative expenses
 
$
69

 
$
67

 
$
79

Production and delivery
 
16

 
17

 
26

Capitalized costs
 
4

 
11

 
23

Total stock-based compensation
 
89

 
95

 
128

Less capitalized costs
 
(4
)
 
(11
)
 
(23
)
Tax benefit and noncontrolling interests' share
 
(3
)
a 
(31
)
 
(41
)
Impact on net loss from continuing operations
 
$
82

 
$
53

 
$
64


a. Charges in the U.S. are not currently expected to generate a future tax benefit.
Summary of stock options and SARs outstanding and changes during the period
A summary of options and SARs outstanding as of December 31, 2016, including 1,034,153 SARs, and activity during the year ended December 31, 2016, follows:
 
Number of
Options and SARs
 
Weighted-
Average
Exercise Price
Per Share
 
Weighted-
Average
Remaining
Contractual
Term (years)
 
Aggregate
Intrinsic
Value
 
Balance at January 1
49,303,879

 
$
34.10

 

 
 
 
Granted
7,167,000

 
4.35

 
 
 
 
 
Exercised
(14,750
)
 
12.12

 

 
 
 
Expired/Forfeited
(2,661,894
)
 
31.80

 

 
 
 
Balance at December 31
53,794,235

 
30.25

 
4.6
 
$
66

 
 
 
 
 
 
 
 
 
 
Vested and exercisable at December 31
44,314,195

 
34.20

 
3.8
 
$
14

 
Weighted average assumptions used to value stock option awards
Information related to stock options during the years ended December 31 follows:
 
2016
 
2015
 
2014
Weighted-average assumptions used to value stock option awards:
 
 
 
 
 
Expected volatility
71.6
%
 
37.9
%
 
36.6
%
Expected life of options (in years)
5.34

 
5.17

 
4.92

Expected dividend rate
—

 
4.5
%
 
3.5
%
Risk-free interest rate
1.3
%
 
1.7
%
 
1.7
%
Weighted-average grant-date fair value (per share)
$
2.64

 
$
4.30

 
$
7.43

Intrinsic value of options exercised
$
—

a 
$
1

 
$
17

Fair value of options vested
$
43

 
$
50

 
$
76

a. Rounds to less than $1 million.

Summary Of Outstanding Stock-settled RSUs and PSUs
A summary of outstanding stock-settled RSUs and PSUs as of December 31, 2016, and activity during the year ended December 31, 2016, follows:
 
Number of Awards
 
Weighted-Average Grant-Date Fair Value Per Award
 
Aggregate
Intrinsic
Value
Balance at January 1
7,220,300

 
$
27.12

 
 
Granted
3,557,366

a 
10.46

 
 
Vested
(3,042,860
)
 
28.81

 
 
Forfeited
(516,579
)
 
25.91

 
 
Balance at December 31
7,218,227

 
18.08

 
$
95

a. Excludes 993 thousand PSUs granted in 2016 for which the performance metrics have not yet been established.

Summary of Outstanding Cash-Settled RSUs and PSUs
A summary of outstanding cash-settled RSUs and PSUs as of December 31, 2016, and activity during the year ended December 31, 2016, follows:
 
Number of Awards
 
Weighted-Average Grant-Date Fair Value Per Award
 
Aggregate
Intrinsic
Value
Balance at January 1
4,612,536

 
$
24.89

 
 
Granted
676,000

 
6.05

 
 
Vested
(2,148,558
)
 
25.83

 
 
Forfeited
(608,234
)
 
23.92

 
 
Balance at December 31
2,531,744

 
19.30

 
$
33
Schedule of amounts related to exercises of stock options and stock appreciation rights and the vesting of restricted stock units and restricted stock awards
The following table includes amounts related to exercises of stock options and vesting of RSUs during the years ended December 31:
 
2016
 
2015
 
2014
FCX shares tendered to pay the exercise price
 
 
 
 
 
and/or the minimum required taxesa
906,120

 
349,122

 
474,480

Cash received from stock option exercises
$
—

b 
$
3

 
$
12

Actual tax benefit realized for tax deductions
$
—

b 
$
11

 
$
16

Amounts FCX paid for employee taxes
$
6

 
$
7

 
$
8

a.
Under terms of the related plans, upon exercise of stock options and vesting of RSUs, employees may tender FCX shares to pay the exercise price and/or the minimum required taxes.
b.
Rounds to less than $1 million.